Abstract

Early detection of cancer significantly improves therapeutic outcomes, enhances patient survival rates, and 
reduces treatment costs. However, conventional diagnostic tools often lack the sensitivity and specificity 
required to detect tumors at their incipient stages. Nanodiagnostics an emerging field at the intersection of 
nanotechnology and medical diagnostics offers a transformative approach for early cancer detection by utilizing 
nanoscale materials and devices to enhance diagnostic precision. This review explores recent advances in 
nanodiagnostic platforms, focusing on biosensors and imaging technologies that leverage unique 
physicochemical properties of nanoparticles. We highlight various nanomaterials such as gold nanoparticles, 
quantum dots, magnetic nanoparticles, and carbon-based nanostructures that are engineered into highly 
sensitive biosensors capable of detecting cancer biomarkers at ultra-low concentrations. Additionally, we 
examine the integration of nanotechnology in imaging modalities, including magnetic resonance imaging 
(MRI), positron emission tomography (PET), computed tomography (CT), and optical imaging, where 
nanoparticle contrast agents significantly enhance image resolution and tumor targeting. The review also 
discusses current clinical challenges, regulatory considerations, and future perspectives for the translation of 
nanodiagnostics into routine cancer screening. Ultimately, nanodiagnostics holds tremendous potential to 
revolutionize oncology by enabling non-invasive, highly accurate, and early detection of malignancies. 
Keywords: Nanodiagnostics, Early Cancer Detection, Biosensors, Imaging Technologies, Nanoparticles